Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

1.89
Delayed Data
As of 4:00pm ET
 +0.04 / +2.16%
Today’s Change
1.51
Today|||52-Week Range
14.10
-86.07%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close1.85
Today’s open1.84
Day’s range1.82 - 1.90
Volume1,487,581
Average volume (3 months)1,268,501
Market cap$161.5M
Dividend yield--
Data as of 4:00pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-135.21%
Earnings growth (this year)-1.21%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-29.86%
P/E ratioNM
Price/Sales4.46
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVIVInVivo Therapeutics ...-0.15-3.16%
QUREUniqure NV+0.37+6.35%
ENZYEnzymotec Ltd0.000.00%
OSIROsiris Therapeutics ...-0.13-2.47%
Data as of 4:00pm ET, 12/08/2016

Financials

Next reporting dateFebruary 3, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$60.0M
Annual profit (last year)-$144.8M
Net profit margin-241.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs